Dr. Hassan Baydoun, MD

Dr. Baydoun practices at Cardiac and Vascular Consultants MD PA in Lecanto, Florida.

Dr. Baydoun's NPI, 1538456256, was assigned on July 1, 2011. Dr. Baydoun graduated from Lebanese University School of Medicine in 2006. Dr. Baydoun holds Florida license ME135479.

Dr. Baydoun's primary practice is Cardiac and Vascular Consultants MD PA, at 4224 W Gulf To Lake Hwy, Lecanto, FL 34461 in Citrus County. The practice phone is (352) 552-4648.

Dr. Baydoun's primary practice is Cardiac and Vascular Consultants MD PA in Lecanto, Florida. Dr. Baydoun is also affiliated with Tampa General Hospital. The medical group on file is Cardiac & Vascular Consultants of Florida. Dmand AI also links Dr. Baydoun to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baydoun practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Baydoun's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Baydoun is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Baydoun's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Baydoun treats.

CMS data shows 7,410 Medicare services from Dr. Baydoun across 50 procedure codes in 2024, for 729 Medicare patients. Medicare paid $462,594 for them.

CMS counts 729 Medicare patients who saw Dr. Baydoun in 2024. The largest group is 75 to 84, with 334 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baydoun's median patient age at 75, with 47% women.

In 2024, Dr. Baydoun wrote 4,340 Medicare Part D claims for 579 patients. 78% of them were for generic drugs. CMS names the drug for 4,088 of them, across 43 drugs with 11 or more claims each, at $894,509 in total drug cost. In 2023, CMS named 3,540 claims across 38 drugs.

Dr. Baydoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of leg revascularization (restoring blood flow) by Dr. Baydoun, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Baydoun, published from 2013 to 2019. 2013 was the busiest year, with 3. The most frequent topics are Atrial Fibrillation, Catheter Ablation and Cryosurgery. Dr. Baydoun has published most often in J Invasive Cardiol. Dr. Baydoun's most frequent co-authors are Dan Dan, MD, Marcin Kowalski, MD and Andrew Craig Wickliffe, MD.

CMS Open Payments shows 333 general payments to Dr. Baydoun from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Abbott Laboratories paid the most, $3,975.

Dr. Baydoun graduated from Lebanese University School of Medicine in 2006. Dr. Baydoun is a member of ACC.

Dr. Baydoun is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.